(CNN) – The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten. A federal deadline to halt sales of the ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...

After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.

Home Online Features What You Need to Know About GLP-1 Weight-Loss Drugs Now That the FDA Says the Shortage Is Over Community ...

As the popularity of weight-loss drugs surges, a new concern is emerging: “Ozempic teeth.” The term refers to a range of dental issues users have reportedly been experiencing — such as dry mouth, bad ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...